2023 Form 5500 filing — Cerevel Therapeutics LLC 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240620084912NAL0002285202001) for Cerevel Therapeutics LLC 401(K) Plan, reported by Cerevel Therapeutics LLC under EIN 83-1334174 and plan number 001. It reports 322 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

Form 5500 2 · 2023

Filing snapshot

Net assets (EOY)$31.3MReported net assets$31,307,889
Participants322
Provider compensation$3.8K1 Schedule C row(s)$3,840
Schedules filedSchedule H, Schedule CLoaded schedules
EFAST2 acknowledgement
20240620084912NAL0002285202001
Plan sponsor
Cerevel Therapeutics LLC
EIN
83-1334174
Plan number
001
Location
Cambridge, MA
Received date
not reported in the loaded dataset
How to read this filing
  • This is a single annual Form 5500 filing, identified by its EFAST2 acknowledgement id.
  • Schedule chips (Sch H / I / C) show which schedules this filing includes.
  • Net assets = total assets minus total liabilities (Schedule H/I).
  • Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
  • For the plan's full history, open the plan profile.
Schedule H · 2023

Reported financial snapshot

Reported figures as filed, in whole dollars. Only fields the filing reports are shown.

Reported balance (end of year)$31.3M total assets
Net assets$31.3MLiabilities$0
Money in vs. money out
Total income / additions$15.9M
Total expenses$1.3M
Benefits paid / distributions$1.3M
Contributions
Employer$3.9M
Participant$5.6M
Full reported line items
Total assets (EOY)
$31,307,889
Total liabilities (EOY)
$0
Net assets (EOY)
$31,307,889
Employer contributions
$3,885,703
Participant contributions
$5,616,442
Total income / additions
$15,923,160
Benefits paid
$1,292,882
Administrative expenses
$3,840
Total expenses
$1,298,811
Net increase / (decrease)
$14,624,349
Schedule C

Reported service provider compensation

Compensation reported on the 2023 filing, ranked by reported total.

  1. 1
    NONE · Direct $3.8K · Indirect $0

What to inspect next

Frequently asked questions

What does EFAST2 acknowledgement 20240620084912NAL0002285202001 cover?
It is the 2023 Form 5500 filing for Cerevel Therapeutics LLC 401(K) Plan, reported by Cerevel Therapeutics LLC (EIN 83-1334174).
Which Form 5500 schedules are attached to this 2023 filing?
Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

Related Form 5500 pages